Literature DB >> 27867027

Therapeutic potential of hepcidin - the master regulator of iron metabolism.

Daniel Vyoral1.   

Abstract

Iron is an essential biogenic element for both prokaryotic and eukaryotic cells. In humans iron is present in hundreds of different metalloproteins. The peptide hormone hepcidin serves as a master regulator of iron homeostasis on the level of single cells and whole organism - by altering cell surface expression of cellular iron exporter - protein ferroportin. Altered levels of extracellular hepcidin lead to pathological conditions such as hemochromatosis and iron loading or, on the other side, iron restrictive anemias. Therapeutic modulation of hepcidin is a new and promising approach to treatment of these conditions. In this review, a summary of the current knowledge of hepcidin function, regulation and pathological involvements are provided, followed by a section covering the therapeutic potential of hepcidin and the current strategies how to modulate its levels and biological functions for therapeutic purposes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anemia of chronic disease; Hemochromatosis; Hepcidin; Iron; Iron deficiency anemia; Iron overload; Iron therapy; Thalassemia

Mesh:

Substances:

Year:  2016        PMID: 27867027     DOI: 10.1016/j.phrs.2016.11.010

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  10 in total

Review 1.  New therapeutic targets in transfusion-dependent and -independent thalassemia.

Authors:  M Domenica Cappellini; Irene Motta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Effects of Lactobacillus casei on Iron Metabolism and Intestinal Microflora in Rats Exposed to Alcohol and Iron.

Authors:  Xuelong Li; Hui Liang
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

Review 3.  Therapeutic Implications of Ferroptosis in Renal Fibrosis.

Authors:  Yao Zhang; Yanhua Mou; Jianjian Zhang; Chuanjian Suo; Hai Zhou; Min Gu; Zengjun Wang; Ruoyun Tan
Journal:  Front Mol Biosci       Date:  2022-05-17

4.  [Expression and influencing factors of hepcidin in classical paroxysmal nocturnal hemoglobinuria].

Authors:  Y S Wang; H J Yao; L J Bo; Y P Zhao; Y L Zhang; F K Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-10-14

Review 5.  Regulation of Iron Homeostasis and Related Diseases.

Authors:  Yikun Li; Xiali Huang; Jingjing Wang; Ruiling Huang; Dan Wan
Journal:  Mediators Inflamm       Date:  2020-05-02       Impact factor: 4.711

Review 6.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

7.  British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults.

Authors:  Jonathon Snook; Neeraj Bhala; Ian L P Beales; David Cannings; Chris Kightley; Robert Ph Logan; D Mark Pritchard; Reena Sidhu; Sue Surgenor; Wayne Thomas; Ajay M Verma; Andrew F Goddard
Journal:  Gut       Date:  2021-09-08       Impact factor: 23.059

8.  Hepcidin is potential regulator for renin activity.

Authors:  Jaakko Piesanen; Jarkko Valjakka; Sanna Niemelä; Marjut Borgenström; Seppo Nikkari; Vesa Hytönen; Juha Määttä; Tarja Kunnas
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.240

9.  Role of Fermented Goat Milk on Liver Gene and Protein Profiles Related to Iron Metabolism during Anemia Recovery.

Authors:  Jorge Moreno-Fernandez; María J M Alférez; Inmaculada López-Aliaga; Javier Díaz-Castro
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

10.  Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients.

Authors:  Ahmet Tufekci; Ekrem Kara
Journal:  Sleep Breath       Date:  2020-10-07       Impact factor: 2.816

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.